191 related articles for article (PubMed ID: 4102340)
21. Tumour specific and embryonic antigen expression of chemically induced rat tumours.
Baldwin RW; Glaves D; Pimm MV; Vose BM
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):715-28. PubMed ID: 4340543
[No Abstract] [Full Text] [Related]
22. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
Stjernswärd J
J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
[No Abstract] [Full Text] [Related]
23. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
Lennox E; Cohn J; Lowe T
Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
[No Abstract] [Full Text] [Related]
24. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
Baldwin RW; Pimm MV
Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
[No Abstract] [Full Text] [Related]
25. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
26. The burn scar as an "immunologically privileged site".
Futrell JW; Myers GH
Surg Forum; 1972; 23(0):129-31. PubMed ID: 4671049
[No Abstract] [Full Text] [Related]
27. Tumor-specific skin-reactive antigen solubilized from a syngeneic guinea pig liposarcoma by 3M potassium chloride.
Kataoka T; Kamiyama T; Tokunaga T
Gan; 1978 Jun; 69(3):427-30. PubMed ID: 78869
[TBL] [Abstract][Full Text] [Related]
28. Cell-mediated immune reactions as probes of sensitization to tumour-associated antigens of methylcholanthrene-induced mouse sarcomas.
Bubeník J; Indrová M; Malkovský M; Símová J
Arch Geschwulstforsch; 1981; 51(4):349-53. PubMed ID: 6172086
[TBL] [Abstract][Full Text] [Related]
29. Antigens on human tumor cells assayed by complement fixation with allogeneic sera.
Gupta RK; Irie RF; Morton DL
Cancer Res; 1978 Aug; 38(8):2573-80. PubMed ID: 78763
[No Abstract] [Full Text] [Related]
30. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
Kitano M; Okada Y; Nagaishi C
Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
[No Abstract] [Full Text] [Related]
31. Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas.
Law LW
Int J Cancer; 1984 Apr; 33(4):547-51. PubMed ID: 6200449
[TBL] [Abstract][Full Text] [Related]
32. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
Fritze D; Kern DH; Waldman SR; Pilch YH
Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
[TBL] [Abstract][Full Text] [Related]
33. Sarcoma induction in mice by methylcholanthrene. Antigenicity tests of sarcomas induced in thymus grafted and control animals.
Marchant J
Br J Cancer; 1969 Jun; 23(2):383-90. PubMed ID: 5788047
[No Abstract] [Full Text] [Related]
34. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
Pellis NR; Tom BH; Kahan BD
J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
[No Abstract] [Full Text] [Related]
35. Tumor autoimmunity against methylcholanthrene-induced sarcomas of the rat.
Takeda K; Aizawa M; Kikuchi Y; Yamawaki S; Nakamura K
Gan; 1966 Jun; 57(3):221-40. PubMed ID: 5962636
[No Abstract] [Full Text] [Related]
36. The antigenicity and immunogenicity of cell-free extracts of chemically induced murine sarcomas.
Pilch YH
Cancer Res; 1968 Dec; 28(12):2502-11. PubMed ID: 4302533
[No Abstract] [Full Text] [Related]
37. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
[No Abstract] [Full Text] [Related]
38. Expression of oncofetal antigens by murine and human normal cells in tissue culture.
Rosenberg SA; Parker GA; Thorpe WP
Isr J Med Sci; 1978 Jan; 14(1):98-104. PubMed ID: 273017
[TBL] [Abstract][Full Text] [Related]
39. [Immunologic characterization of sarcomas artificially infected with Graffi leukemia virus. II. Studies on the differentiation between viral and new cellular antigens].
Pasternak L; Pasternak G
Arch Geschwulstforsch; 1968; 32(4):301-8. PubMed ID: 4308111
[No Abstract] [Full Text] [Related]
40. Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.
Mondal S; Iype PT; Griesbach LM; Heidelberger C
Cancer Res; 1970 Jun; 30(6):1593-7. PubMed ID: 5457933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
